Viscum Mali Rk 30x
Generic Name: viscum mali rk 30x
Brand Names:
Viscum Mali Rk 30x
For contitutional treatments based on homeopathic and anthroposophic indications or as directed by your physician.
Overview
For contitutional treatments based on homeopathic and anthroposophic indications or as directed by your physician.
Uses
Use: For contitutional treatments based on homeopathic and anthroposophic indications or as directed by your physician.
Dosage
Directions for Use: Place drops under tongue for 30 seconds. Adults3-5 drops 3 times a day. Children 2-12 years--3-5 drops 3 times a day. Under 2 years, consult your doctor. Use until symptoms are relieved or as directed by your health care provider.
Warnings
Warnings: Consult your health care provider if symptoms persist more than 5 days or worsen. TAMPER EVIDENT: Do not use if safety seal is broken before first use.
Pregnancy
If pregnant or breastfeeding ask a health professional before use.
Frequently Asked Questions
What is Viscum Mali Rk 30x used for?▼
Use: For contitutional treatments based on homeopathic and anthroposophic indications or as directed by your physician.
Can I take Viscum Mali Rk 30x during pregnancy?▼
If pregnant or breastfeeding ask a health professional before use.
What are the important warnings for Viscum Mali Rk 30x?▼
Warnings: Consult your health care provider if symptoms persist more than 5 days or worsen. TAMPER EVIDENT: Do not use if safety seal is broken before first use.
Related Medications
Talimogene Laherparepvec
talimogene laherparepvec
11 DESCRIPTION IMLYGIC (talimogene laherparepvec) is a sterile suspension for intralesional injection. IMLYGIC is a live, attenuated HSV-1 that has been genetically modified to express huGM-CSF. The parental virus for IMLYGIC was a primary isolate, which was subsequently altered using recombinant methods to result in gene deletions and insertions.
Tisotumab Vedotin
tisotumab vedotin
11 DESCRIPTION Tisotumab vedotin-tftv is a Tissue Factor (TF) directed antibody drug conjugate (ADC) comprised of a human anti-TF IgG1-kappa antibody conjugated to the microtubule-disrupting agent monomethyl auristatin E (MMAE) via a protease-cleavable vc (valine-citrulline) linker. The monoclonal antibody is produced in a mammalian cell line (Chinese hamster ovary). MMAE and the linker are produced by chemical synthesis. Each monoclonal antibody molecule carries an average of 4 MMAE molecules.
Cosibelimab
cosibelimab
Programmed Death Ligand-1 Blocker [EPC]
11. DESCRIPTION Cosibelimab-ipdl is a human programmed death ligand-1 (PD-L1) blocking antibody. Cosibelimab-ipdl is a human IgG1 lambda monoclonal antibody. Cosibelimab-ipdl is produced in Chinese hamster ovary (CHO) cells and has a calculated molecular weight of approximately 147 kDa. UNLOXCYT (cosibelimab-ipdl) injection for intravenous use is a sterile, preservative-free, clear to opalescent, colorless to yellow or slightly brown solution. It is supplied in single-dose vials.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.